An integrated pest management approach combining novel clay particle repellents with metallic reflective mulches to disrupt whitefly host-finding behavior and reduce Tomato yellow leaf curl virus (TYLCV) incidence in tomato crops. Designed to address limitations of current resistant cultivars under high virus pressure.
Tomato production faces significant threats from viruliferous whiteflies that transmit Tomato yellow leaf curl virus (TYLCV), a highly destructive pathogen. Existing resistant cultivars often carry poor horticultural traits and remain vulnerable under high disease pressure and direct feeding damage. This research proposes an integrated pest management system that combines novel clay mineral particle repellents with metallic reflective mulches to disrupt whitefly host-finding behavior and reduce viral transmission in tomato fields.
The approach targets the whitefly's olfactory and visual cues, repelling the insect before it can probe and feed on plant tissue. By coating plants with clay particles to reduce palatability and using reflective mulches to interfere with visual orientation, the system aims to lower whitefly populations below the threshold needed to suppress TYLCV spread.
Core technology components:
Mechanism of action:
Validation approach:
This research builds on prior findings demonstrating that clay particles can reduce whitefly populations by creating a protective whitish coating on plant surfaces. However, previous trials showed that population reductions alone did not decrease viral incidence under high disease pressure, likely because rapid plant growth exposed uncoated tissue to feeding. This validation phase addresses that limitation by integrating reflective mulches for early-season protection and optimizing clay application frequency. Two field trials are planned to evaluate the combined system's effectiveness under commercial-style conditions, positioning the technology for further development toward practical deployment in tomato production systems.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.